Home Journals About My LA Reviewers Authors News Submit
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


 Yes, sign up now
 Sign up for general news too

Privacy Statement

Cardiovascular disorders


Cardiovascular disorders research articles, Cardiovascular disorders research article, Cardiovascular disorders journals, Cardiovascular disorders journal, Cardiovascular disorders articles, Research on Breast cancer, Cardiovascular disorders



Sign up for free journal updates
How should we address you?
Your email address
 Yes, sign up now

peer reviewed open access journals 79




Latest news
  • Interview with Cancer Informatics editorial board member Dr Grant Izmirlian
  • - 22/Sep/2009
  • Sponsor the IBM-OCI Integrative Discovery team in Ride to Conquer Cancer
  • - 15/Sep/2009
  • No article processing fees for selected journals
  • - 15/Sep/2009
  • Newsletter summary (week 36, 2009)
  • - 15/Sep/2009
  • Interview with Healthy Aging and Clinical Care in the Elderly editorial board member Dr Davide Malatesta
  • - 15/Sep/2009
  • Interview with Translational Oncogenomics author Dr David Frank
  • - 10/Sep/2009
  • Interview with Retrovirology: Research and Treatment author Dr Elcio Leal
  • - 10/Sep/2009
  • Interview with Microbiology Insights author Dr Tinatin Doolotkedlieva
  • - 10/Sep/2009
  • Call for papers for Drug Target Insights by Dr Monica Milani
  • - 10/Sep/2009
  • Call for papers for Clinical Medicine: Urology from Dr Xiangyi Lu
  • - 10/Sep/2009
  • Research profile on Gene Regulation and Systems Biology author Dr Noboru Uchide
  • - 09/Sep/2009
  • Interview with Biomarker Insights editorial board member Dr Lawrence Cheskin
  • - 07/Sep/2009
  • Newsletter summary (week 35, 2009)
  • - 04/Sep/2009
  • Research profile of Clinical Medicine: Endocrinology and Diabetes author Dr Hiro Koshiyama
  • - 04/Sep/2009
  • Open access articles published in August
  • - 03/Sep/2009
  • Call for papers for Clinical Medicine: Circulatory, Respiratory and Pulmonary Medicine from Dr Hussein Foda
  • - 03/Sep/2009
  • Interview with Cancer Informatics editorial board member Dr Georgios S. Stamatakos
  • - 03/Sep/2009
  • Announcing mobile Libertas Academica website
  • - 02/Sep/2009
  • Call for papers for Particle Physics Insights from Dr Hanna Moussa
  • - 02/Sep/2009
  • Call for papers for Clinical Medicine: Dermatology from Dr Robert Pearl
  • - 01/Sep/2009
  • Interview with Immunotherapy Insights editorial board member Dr Stéphanie McArdle
  • - 01/Sep/2009
  • Interview with Cell Communication Insights editorial board member Dr John S Torday
  • - 01/Sep/2009
  • Interview with Translational Oncogenomics editorial board member Dr James Connor
  • - 31/Aug/2009
  • Interview with Glycobiology Insights editorial board member Dr Alberto Passi
  • - 31/Aug/2009

Latest pictures




Latest articles

Most read articles


(previous 30 days)Site updates
59
Articles published:
4
Comments:
25
Blog entries:

Journal: Clinical Medicine: Cardiology

Editor in Chief: Martin M. LeWinter   |   Table of contents   |   76015 views
Get Updates
Get Updates
Abstract
Full-text PDF

Left Ventricular Rupture Post Mitral Valve Replacement     (23/Sep/2009)


Prevention is better than cure best applies here. As per many authors, posterior leaflet chordae preservation prevent Left ventricular rupture (LVR) and preserve LV geometry. We are presenting here 5 types of left ventricular rupture (LVR) post Mitral valve replacement (MVR) with different methods to repair with the advantages and...


Abstract
Full-text PDF

Good News from Aliskiren?     (17/Sep/2009)


The renin-angiotensin system can be inhibited through inhibition of angiotensin I generation from angiotensinogen by direct renin inhibitors, inhibition of angiotensin II generation from angiotensin I by angiotensin-converting enzyme inhibitors and by direct inhibition of the action of angiotensin II receptor level. Aliskiren, the first direct renin inhibitor to reach...


Abstract
Full-text PDF

Stress Cardiomyopathy (Takotsubo Cardiomyopathy)     (17/Sep/2009)


Background: Due to the rise in the number of reports of stress cardiomyopathy in the literature, awareness of this condition is increasing. Although different names have been used to describe this condition, the similarities in clinical, electrocardiographic, echocardiographic, and angiographic features suggest that they represent the same spectrum of diseases...


Abstract
Full-text PDF

Aliskiren for the Treatment of Hypertension: An Update     (15/Sep/2009)


Hypertension can lead to significant morbidity and mortality, and requires lifestyle modifications with or without drug therapy to achieve target blood pressure control. Various classes of anti-hypertensive medications are available to healthcare providers. Choice of medications is based not only on efficacy but also tolerability and cost. Aliskiren is the...


Abstract
Full-text PDF

Antiplatelet Resistance - Does it Exist and How to Measure it?     (03/Sep/2009)


Aspirin and clopidogrel are the most commonly used antiplatelet agents in patients with coronary artery disease. The existence of resistance to these agents has been a controversial issue and new drugs are being developed to overcome this problem. Laboratory tests, which can identify resistance and correlate this with clinical outcome,...


Abstract
Full-text PDF

Reduction in Risk of Myocardial Infarction, Stroke, and Death from Cardiovascular Causes. Focus on Rampiril     (31/Aug/2009)


Several clinical studies demonstrate a beneficial role of angiotensin-converting enzyme (ACE) inhibitors in patients with myocardial infarction, hypertension and diabetes mellitus. This review focuses on the effects of ramipril, a weak inhibitor of ACE that is rapidly hydrolyzed to ramiprilat, an active metabolite. The Heart Outcome Prevention Evaluation (HOPE) study...


Abstract
Full-text PDF

Cardiotoxicity of Oral Methadone as an Analgesic - Recommendations for Safe Use     (31/Aug/2009)


Once used only as third-line therapy in the management of chronic pain states, methadone is now being used as first- and second-line therapy. Most risks and the stigma associated with methadone use have been known for years. Only over the past decade or so have the unique pharmacokinetic-pharmacodynamic properties and...


Abstract
Full-text PDF

Safety and Efficacy of Eplerenone in the Management of Essential Hypertension     (25/Aug/2009)


Suppression of the Renin-Angiotensin-Aldosterone system (RAAS) is an established intervention in the management of cardiovascular disease. Large, randomized controlled trials have provided a sound evidence base for the use of mineralocorticoid receptor antagonists to block the end product of the RAAS in the treatment of heart failure. However, the place...


Abstract
Full-text PDF

Clopidogrel Bisulfate: A Review of its Use in the Management of Acute Coronary Syndrome     (07/Aug/2009)


Antiplatelet therapy is the cornerstone in the modern therapy of patients with acute coronary syndromes (ACS), because of the unique role of platelets in coronary thrombosis. Clopidogrel in combination with aspirin is the current “gold standard” for reducing cardiovascular events in such patients, providing a synergistic platelet inhibition through different...


Abstract
Full-text PDF

Management Options in Chronic Stable Angina Pectoris: Focus on Ranolazine     (31/Jul/2009)


Chronic stable angina pectoris results from a fixed coronary arterial obstruction causing an imbalance between myocardial oxygen supply and demand. Current therapy aims to reduce cardiovascular events (vasculoprotective) thereby improving survival, and/or relieve ischemic symptoms (antianginal) thereby improving the quality of life. Vasculoprotective therapy consists of lifestyle modification, antiplatelet agents,...


Abstract
Full-text PDF

Safety and Efficacy of the bi-Sulfydryl ACE-Inhibitor Zofenopril in the Management of Cardiovascular Disease     (15/Jul/2009)


In the 1970s, pharmacological therapy interrupting the renin-angiotensin system was considered beneficial for patients with high-renin hypertension. Angiotensin-converting enzyme (ACE) inhibitors proved to be effective not only in patients with high renin and elevated blood pressure, but also in many hypertensive patients with normal levels of plasma renin activity. ACE...


Abstract
Full-text PDF

Introductory Editorial      (09/Jul/2009)


Garry Walsh Reader in Inflammation and Immunity, University of Aberdeen Scotland, United Kingdom.


Abstract
Full-text PDF

Introductory Editorial      (09/Jul/2009)


Garry Walsh Reader in Inflammation and Immunity, University of Aberdeen Scotland, United Kingdom.


Abstract
Full-text PDF

Single Sevikar®: Combination Therapy for the Treatment of Hypertension     (01/Jul/2009)


Hypertension is one of the most important modifiable risk factor for cardiovascular morbidity and mortality and is highly prevalent. Recent guidelines and advisory statements have recommended lower thresholds and goals for patients with hypertension. However, approximately two-thirds of hypertensive patients do not achieve the goals. Poor adherence to anti-hypertensive medication...


Abstract
Full-text PDF

HMGCoA-Reductase Inhibitors in Dementia: Benefit or Harm     (12/Jun/2009)


Dementia is a syndrome characterized by a decline in cognitive function. Alzheimer’s disease and cerebro-vascular disease are the most common causes of dementia. Many factors (genetic, life style, vascular etc.) appear to play some role in the development of dementia. Statins significantly reduce vascular disease and could reduce cognitive impairment...


Article: Assessment of Myocardial Scar; Comparison Between <sup>18</sup>F-FDG PET, CMR and <sup>99</sup>Tc-Sestamibi
Full-text PDFAbstract

Assessment of Myocardial Scar; Comparison Between 18F-FDG PET, CMR and 99Tc-Sestamibi     (08/Jun/2009)


Objective: Patients with heart failure and ischaemic heart disease may obtain benefit from revascularisation if viable dysfunctional myocardium is present. Such patients have an increased operative risk, so it is important to ensure that viability is correctly identified. In this study, we have compared the utility of 3 imaging modalities to detect myocardial scar. Design: Prospective, descriptive study. Setting: Tertiary cardiac centre. Patients: 35 patients (29 male, average age 70 years) with coronary artery disease and symptoms of...


Abstract
Full-text PDF

Pharmacotherapy of Excessive Sleepiness: Focus on Armodafinil     (28/May/2009)


Excessive sleepiness (ES) is responsible for significant morbidity and mortality due to its association with cardiovascular disease, cognitive impairment, and occupational and transport accidents. ES is also detrimental to patients’ quality of life, as it affects work and academic performance, social interactions, and personal relationships. Armodafinil is the R-enantiomer of...


Abstract
Full-text PDF

Circulating CD34+ Cell Count is Associated with Extent of Subclinical Atherosclerosis in Asymptomatic Amish Men, Independent of 10-Year Framingham Risk     (27/May/2009)


Background: Bone-marrow derived progenitor cells (PCs) may play a role in maintaining vascular health by actively repairing damaged endothelium. The purpose of this study in asymptomatic Old Order Amish men (n = 90) without hyper- tension or diabetes was to determine if PC count, as determined by CD34+ cell count...


Abstract
Full-text PDF

Pathway Analysis of Differentially Expressed Genes in Patients with Acute Aortic Dissection     (06/May/2009)


Background: Acute aortic dissection (AAD) is a life-threatening condition with high mortality and a relatively unclarified pathophysiological mechanism. Although differentially expressed genes in AAD have been recognized, interactions between these genes remain poorly defined. This study was conducted to gain a better understanding of the molecular mechanisms underlying AAD and...


Abstract
Full-text PDF

Hypertension Management and End Organ Protection: Focus on Aliskiren     (01/May/2009)


Toshio Imanishi, Hiroto Tsujioka and Takashi AkasakaDepartment of Cardiovascular Medicine, Wakayama Medical University. 811-1, Kimiidera, Wakayama City, Wakayama, Japan.AbstractThe renin-angiotensin system (RAS) activity is a key factor in the pathophysiology and development of hypertension, atherosclerosis, heart failure, and renal disease. It is unclear whether angiotensin-converting-enzyme (ACE) inhibitors and angiotensin-receptor blockers...


Abstract
Full-text PDF

Efficacy and safety of fixed-dose Lercanidipine-Enalapril for the treatment of hypertension     (20/Apr/2009)


Christos Chatzikyrkou, Hermann Haller and Jan MenneDepartment of Nephrology, Hannover Medical School, Germany.AbstractHypertension is the most important preventable cause of premature death in the developed countries, and the benefits of antihypertensive drugs regarding cardiovascular morbidity and mortality are well established. Nevertheless, adequate control is achieved only in the minority of...


Abstract
Full-text PDF

Improvement of Young and Elderly Patient’s Knowledge of Heart Failure After an Educational Session     (20/Apr/2009)


Jérôme Roncalli1,2, Laurence Perez1, Atul Pathak1,3, Laure Spinazze1, Sandrine Mazon1, Olivier Lairez1, Daniel Curnier2, Joëlle Fourcade1, Meyer Elbaz1, Didier Carrié1, Jacques Puel1,4, Jean-Marie Fauvel1 and Michel Galinier1,21Rangueil University Hospital, Department of Cardiology and Heart Failure Educational Centre (Centre d’ Education pour Patient Insuffisant Cardiaque (CEPIC)), Toulouse, France. 2INSERM U858-I2MR, Hôpital...


Abstract
Full-text PDF

Pharmacotherapy Options in Atrial Fibrillation: Focus on Vernakalant     (17/Apr/2009)


Judy W.M. Cheng1 and Iwona Rybak21Professor of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences and Clinical Pharmacist, Brigham and Women’s Hospital, Boston, MA, U.S.A. 2Doctor of Pharmacy Candidate, Massachusetts College of Pharmacy and Health Sciences, Boston, MA, U.S.A.AbstractThis article reviews the role of vernakalant in the management of...


Abstract
Full-text PDF

Platypnea-Orthodeoxia Syndrome in Two Previously Healthy Adults: A Case-based Review     (09/Apr/2009)


Leon M. Ptaszek1, Fidencio Saldana2, Igor F. Palacios1 and Sean M.Wu11Cardiology Division, Massachusetts General Hospital, Boston, MA 02114. 2Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Boston, MA 02115.AbstractWe describe here the clinical manifestations of platypnea-orthodeoxia in two patients with interatrial shunting. In both cases, the patients were asymptomatic prior...


Abstract
Full-text PDF

The Threshold of Admission Glycemia as a Predictor of Adverse Events in Diabetic and Non-Diabetic Patients with Acute Coronary Syndrome     (01/Apr/2009)


Taysir S. Garadah1, Salah Kassab2, Qasim M. Al-Shboul2 and Abdulhai Alawadi11Cardiac Unit, Salmaniya Medical Complex. 2College of Medicine and Medical Sciences, Arabian Gulf University, Manama, Kingdom of Bahrain.AbstractRecent studies indicated a high prevalence of hyperglycemia in non-diabetic patients presenting with acute coronary syndrome (ACS). However, the threshold of admission glucose...


Abstract
Full-text PDF

Do Patients Profit from Third Time CABG?     (23/Mar/2009)


Introduction: It has been shown that in experienced hands repeated CABG is doable procedure. However the quality of life after third time CABG has not been evaluated so far. Patients and Methods: The peri-operative data of 25 (22 male, mean age of 65.5 ± 8.0 years) consecutive patients in a single...


Abstract
Full-text PDF

The Recent Concept of Heart Function in Elderly Patients     (16/Mar/2009)


Ryotaro Wake1, Hidetaka Iida2, Shinichi Shimodozono2, Yukio Yamada2, Takanori Kusuyama2, Hiroaki Takeshita2 and Minoru Yoshiyama11Department of Internal Medicine and Cardiology, Osaka City University Graduate School of Medicine, Osaka, Japan. 2Department of Cardiology, Tsukazaki Hospital, Hyogo, Japan. AbstractAn epidemic increase in heart failure (HF) mortality, hospitalization, and prevalence rates has been...


Abstract
Full-text PDF

Age-Related Alteration of Risk Profile, Inflammatory Response, and Angiographic Findings in Patients with Acute Coronary Syndrome     (18/Feb/2009)


Hala Mahfouz Badran, Mohamed Fahmy Elnoamany, Tarek Salah Khalil and Mostafa Mohamed Ezz EldinCardiology Department, Faculty of Medicine, Menoufiya University, Shebin El Kom, Egypt.AbstractBackground: Coronary artery disease (CAD) is a major public health problem which in turn imposes a significant burden on health care systems because of high morbidity and...


Abstract
Full-text PDF

Initial Cardiac Rhythm Correlated to Emergency Department Survival     (09/Feb/2009)


Rade B. VukmirCritical Care Medicine Associates, Sewicley, PA 15143, U.S.A. Department of Emergency Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, U.S.A.AbstractBackground:  This study attempted to correlate the initial cardiac rhythm and survival from prehospital cardiac arrest, as a secondary end-point.Methods:  Prospective, randomized, double-blinded clinical intervention trial where bicarbonate...


Abstract
Full-text PDF

Women, Environments and Chronic Disease: Shifting the Gaze from Individual Level to Structural Factors     (23/Jan/2009)


Natalie Hemsing1 and Lorraine Greaves21Tobacco Research Coordinator, British Columbia Centre of Excellence for Women’s Health, Vancouver, British Columbia, Canada. 2Executive Director, British Columbia Centre of Excellence for Women’s Health, Vancouver, British Columbia, Canada.AbstractIntroduction: Chronic heart and respiratory diseases are two of the leading causes of morbidity and mortality affecting women....